CH Biotech R&D Co., Ltd. announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was TWD 702.189 million compared to TWD 840.680 million a year ago. Operating income was TWD 145.074 million compared to TWD 257.833 million a year ago. Net income was TWD 100.162 million compared to TWD 190.465 million a year ago. Basic earnings per share from continuing operations was TWD 1.19 compared to TWD 2.26 a year ago. Diluted earnings per share from continuing operations was TWD 1.18 compared to TWD 2.23 a year ago.